PT Asuransi Jiwa Inhealth Indonesia started its journey as a commercial health insurance programs as a business unit of PT Askes (Persero).
PT Asuransi Jiwa Inhealth Indonesia was ofcially established as a legal entity by its founders, PT Askes (Persero) and Koperasi Bhakti PT Askes (Persero).
Ownership of PT Asuransi Jiwa Inhealth Indonesia was transferred to an SOE consortium in the frst acquisition phase consisting of PT Bank Mandiri (Persero), Tbk. (60%), BPJS Kesehatan (20%), PT Kimia Farma Tbk. (10%) and PT Asuransi Jasa Indonesia (Persero) (10%). This is an important milestone for the company in terms of fnance, expertise, marketing, and distribution.
Bank Mandiri executed the second acquisition phase and distributed the Company’s shares to PT Bank Mandiri (Persero), Tbk. (80%), PT Kimia Farma Tbk. (10%), and PT Asuransi Jasa Indonesia (Persero) Tbk. (10%).
As of June 16, 2022, a conditional share sale and purchase process has occurred which has resulted in changes to the composition of Mandiri Inhealth's shareholdings, which became Bank Mandiri, which retains 80% ownership, Kimia Farma retains 10% and PT Bahana Pembinaan Usaha Indonesia or Indonesia Financial Group (IFG). now owns 10% Shares.
On July 31, 2022 Mandiri Inhealth collaborated with PT Mandiri Capital Indonesia (MCI) and also PT Metra Digital Investama (MDI Ventures) by jointly establishing the company PT FitAja Digital Nusantara (FDN) which will act as the manager of SuperApp FitAja!, a front-end application. end Health services created in order to expand access to the Digital Healthcare SuperApp to all levels of Indonesian society.